On July 8, 2020, the U.S. Food and Drug Administration (“FDA”) delivered the results of its most comprehensive sampling study on the current cannabidiol (“CBD”) marketplace to the U.S. House Committee on Appropriations and the U.S. Senate Committee on Appropriations.1 Congress mandated FDA to … Read more about FDA Delivers Latest CBD Study to Congress
OMB Issues Report on Costs and Benefits of Federal Regulations
The nonpartisan White House Office of Management and Budget (OMB) has released a report breaking down the costs and benefits of various federal regulations. The report analyzed federal regulations considered "major" - meaning that they have $100 million or more in economic impact - over a ten … Read more about OMB Issues Report on Costs and Benefits of Federal Regulations